Total Payments
$428.71
2023 Payments
$18.84
Companies
9
Transactions
31
Medicare Patients
678
Medicare Billing
$118,737
Payment Breakdown by Category
Food & Beverage$428.71 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $428.71 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $164.67 | 14 | $0 (2018) |
| Alkermes, Inc. | $55.53 | 3 | $0 (2023) |
| Takeda Pharmaceuticals America, Inc. | $54.12 | 4 | $0 (2017) |
| Lundbeck LLC | $39.71 | 3 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $30.01 | 2 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $26.73 | 2 | $0 (2019) |
| NxStage Medical, Inc. | $24.34 | 1 | $0 (2018) |
| Shire North American Group Inc | $20.14 | 1 | $0 (2017) |
| ACADIA Pharmaceuticals Inc | $13.46 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $18.84 | 1 | Alkermes, Inc. ($18.84) |
| 2019 | $15.36 | 1 | Avanir Pharmaceuticals, Inc. ($15.36) |
| 2018 | $98.76 | 7 | Sunovion Pharmaceuticals Inc. ($44.41) |
| 2017 | $295.75 | 22 | Sunovion Pharmaceuticals Inc. ($120.26) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/15/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: CNS | ||||||
| 07/24/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/12/2018 | NxStage Medical, Inc. | System One (Device) | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: Nephrology | ||||||
| 09/12/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: CNS | ||||||
| 08/17/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: CNS | ||||||
| 07/11/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: CNS | ||||||
| 05/22/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: PSYCHIATRY | ||||||
| 04/18/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: CNS | ||||||
| 02/27/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: CNS | ||||||
| 11/15/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CNS | ||||||
| 10/09/2017 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: CNS | ||||||
| 09/06/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: CNS | ||||||
| 08/10/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: CNS | ||||||
| 08/04/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: PDP | ||||||
| 08/02/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $1.98 | General |
| Category: CNS | ||||||
| 07/13/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: CNS | ||||||
| 06/06/2017 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: PSYCHIATRY | ||||||
| 05/24/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/24/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: CNS | ||||||
| 04/18/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: CNS | ||||||
| 03/27/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/22/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 72 | 320 | $41,620 | $20,562 |
| 2022 | 2 | 73 | 356 | $46,660 | $21,354 |
| 2021 | 3 | 95 | 452 | $60,170 | $28,773 |
| 2020 | 10 | 438 | 747 | $74,785 | $48,047 |
Total Patients
678
Total Services
1,875
Medicare Billing
$118,737
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 302 | $37,750 | $19,452 | 51.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 18 | 18 | $3,870 | $1,110 | 28.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 51 | 332 | $41,500 | $19,316 | 46.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 22 | 24 | $5,160 | $2,038 | 39.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 52 | 407 | $50,875 | $24,661 | 48.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 25 | 26 | $5,590 | $2,157 | 38.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 18 | 19 | $3,705 | $1,956 | 52.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 47 | 194 | $19,993 | $15,289 | 76.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 59 | 75 | $14,914 | $10,907 | 73.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 38 | 102 | $9,739 | $5,882 | 60.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 41 | 52 | $5,506 | $3,786 | 68.8% |
| 98968 | Telephone assessment and management service, 21-30 minutes of medical discussion | Office | 2020 | 84 | 105 | $7,035 | $3,077 | 43.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 16 | 19 | $2,567 | $1,885 | 73.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 38 | 47 | $5,045 | $1,799 | 35.7% |
| 98967 | Telephone assessment and management service, 11-20 minutes of medical discussion | Office | 2020 | 69 | 86 | $3,870 | $1,733 | 44.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 12 | 12 | $2,451 | $1,341 | 54.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 20 | $2,314 | $1,266 | 54.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 16 | 35 | $1,351 | $1,084 | 80.2% |
About Xiaolin Deng, M.D., PH.D
Xiaolin Deng, M.D., PH.D is a Psychiatry healthcare provider based in Aberdeen, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1205001120.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Xiaolin Deng, M.D., PH.D has received a total of $428.71 in payments from pharmaceutical and medical device companies, with $18.84 received in 2023. These payments were reported across 31 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($428.71).
As a Medicare-enrolled provider, Deng has provided services to 678 Medicare beneficiaries, totaling 1,875 services with total Medicare billing of $118,737. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Aberdeen, SD
- Active Since 04/23/2008
- Last Updated 11/29/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1205001120
Products in Payments
- LATUDA (Drug) $164.67
- Trintellix (Drug) $54.12
- REXULTI (Drug) $39.71
- Aristada 441 mg (Drug) $36.69
- ABILIFY MAINTENA (Drug) $30.01
- NUEDEXTA (Drug) $26.73
- System One (Device) $24.34
- MYDAYIS (Drug) $20.14
- Vivitrol (Drug) $18.84
- NUPLAZID (Drug) $13.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Aberdeen
Ms. Sahar Awad, Md, MD
Psychiatry — Payments: $12,156
Psychiatry $12,156
Mr. Maher Awad, Md, MD
Psychiatry — Payments: $11,008
Psychiatry $11,008
Hina Aamir, M.d, M.D
Psychiatry — Payments: $4,489
Psychiatry $4,489
Robert Bennett, Md, MD
Psychiatry — Payments: $4,004
Psychiatry $4,004
Dr. Chandrika Nadipuram, M.d, M.D
Psychiatry — Payments: $3,452
Psychiatry $3,452
Ranjana Verma, M.d, M.D
Psychiatry — Payments: $3,402
Psychiatry $3,402